25 release. Gilead has an array of HIV drugs on the market, which brought in a combined $5.1 billion in sales in the third ...

Importantly, for HCV, combination of antiviral drugs with immunomodulatory interferons may eradicate the infection, something that still seems a distant goal for HIV therapy. Although HIV and HCV ...

This article explores the difficulties faced in attempting to treat HIV, an innovative prevention strategy and the ...

An immune response that likely evolved to help fight infections appears to be the mechanism that drives human ...

But unlike the many, more common antiviral drugs that can be used to fight against viruses such as flus, protease inhibitors can also be used to help combat HIV (human immunodeficiency virus).

Dolutegravir is an HIV integrase strand transfer inhibitor ... integrase mutations to significantly impair dolutegravir antiviral activity. Dolutegravir is well tolerated with few treatment ...

and other HIV drugs. The results, published in The Journal of Controlled Release, may lead to a long-acting, refillable implant that delivers an HIV antiviral medication, Islatravir, into humans ...

Such laws were passed in the early days of the AIDS epidemic, before the advent of highly effective antiviral drugs, which ...

Unlike other antiviral HIV therapies, lenacapavir targets multiple steps of viral replication. The drug has also proved highly successful in clinical trials, as a Pre-Exposure Prophylaxis (PrEP ...

HIV Infection Statistics Underpin Market Expansion Current epidemiological data underscores the need for continued innovation and access to antiviral drugs. With approximately 39 million people ...

Business which accounts for close to one-third of group sales also took in €437m in dividends from subsidiaries dotted ...